Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05558423
Other study ID # ZHS-IF
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 24, 2022
Est. completion date October 24, 2023

Study information

Verified date September 2022
Source Zoe Global Limited
Contact Christina Hu
Phone 07950 335916
Email zoehealthstudy@kcl.ac.uk
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The timing of food intake (chrononutrition) is emerging as a key regulator of circadian rhythm in metabolic organs. A wealth of research has been conducted on intermittent fasting, and time restricted eating (TRE) specifically, investigating the temporal patterns of diet (eating window, time of eating, time of largest energy intake) and their impact on disease risk, with overall beneficial impact on health. Studies have been conducted in a parallel or single arm design, while cross-over and the efficacy of TRE in ameliorating appetite and symptom burden within an individual remains unclear.


Description:

Time Restricted Eating (TRE; a type of intermittent fasting) is a dietary pattern based on the 24h day. Practicing individuals restrict their eating/feeding window to a certain number of hours, e.g. 4h, while the remaining hours in the day are non-feeding (fasting) time. The eating window is the duration of time from the start of the first meal to the end of the last meal in a 24 hr period. The eating window in a general population has previously been quantified at 12h (American cohort of n=15,000). It is important to note that TRE differs from other intermittent fasting protocols by (i) not specifying a change in dietary intake, such as requiring caloric restriction, but rather specifying the temporal pattern of intake; and (ii) requiring consistent daily eating windows over several days. TRE protocols can vary in the length of the eating window, as well as the anchoring of that window to the time of day, such that early vs. middle vs. late TRE regimens exist. While the cardiometabolic benefits TRE are well established by human trials, other outcomes of dietary compliance remain unexplored and thus bring into question the sustainability of and adherence to TRE as a long-term dietary regimen. Perception of hunger, mood and energy, and self-elected timings of TRE eating windows while following the dietary pattern are not well understood. In particular, the relative differences in these outcomes between an habitual and a TRE eating pattern within the same individual must be determined in order to truly evaluate the acceptability of TRE on a per-individual basis. The Intermittent Fasting Study, a sub-study of the ZOE Health Study (ZHS), will test the effects of habitual eating patterns vs. a TRE protocol on hunger, mood, energy and symptom burden in an adult UK cohort using the ZHS app. Population: This study is open to all participants currently enrolled in the ZHS study tracking physical and mental symptom burden on a daily basis. Participants will be invited to take part in the Intermittent Fasting Study and must provide their consent in order to participate. Design: The study will take place remotely using a n-of-1 design, consisting of two phases with a non-randomised cross-over. Firstly, the participant will complete a baseline phase of one week, where they follow their habitual eating pattern. Secondly, for the second and third weeks of the study, the participant will be asked to follow a TRE regimen with an eating window of ≤10 hours. The exact duration of the eating window, its timing relative to time of day, and participant dietary intake, are decisions deliberately left to the participant for two reasons; (i) to enable the participant to choose exactly the right TRE protocol that is most acceptable to them and therefore most likely to be sustainable in the long-term; (ii) to understand the trends in acceptability and feasibility of TRE regimens across this UK cohort. The participant is given the option of continuing their TRE phase beyond the minimum two weeks. During the two phases, participants are asked to log the following outcomes in the ZHS app, on a daily basis: - Hunger (using visual analogue scales, VAS) - Mood (using VAS) - Energy (using VAS) - Symptom burden (using VAS) - Body weight (optional) - Clock time of the start of their first eating event - Clock time of the end of their last eating event Participants may also be asked to log their diet during their baseline phase and their TRE phase (optional) such that the temporal effect of changing between their habitual and chosen TRE regimens on dietary intake can be determined. They will also be asked to complete questionnaires, at the start and end of the study, about their eating habits, gastrointestinal health, lifestyle and demographic. Outcome analysis may be stratified according to demographic and other exposure parameters such as early vs. late TRE.


Recruitment information / eligibility

Status Recruiting
Enrollment 150000
Est. completion date October 24, 2023
Est. primary completion date October 24, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Participants on the ZOE Health Study (ZHS) app are accepted onto the study if they wish to participate and are within the UK. The ZHS eligibility criteria are as follows: Inclusion Criteria: - Adults of 18 years and above, where the app has been approved for download from the Apple App and Google Play stores. Exclusion Criteria: - Unable to provide written informed consent

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Time Restricted Eating
Participants are asked to follow a Time Restricted Eating regimen with eating window of =10 hours.

Locations

Country Name City State
United Kingdom ZOE Limited London

Sponsors (2)

Lead Sponsor Collaborator
Zoe Global Limited King's College London

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary TRE window clock time The chosen clock time for the TRE window (early, vs. middle, vs. late) 2 weeks
Primary Habitual eating window clock time The chosen clock time for the habitual eating window 1 weeks
Primary Hunger Hunger levels reported by visual analogue scale ("how hungry did you feel yesterday?"; 0-10; where 10 is the most hungry) 3 weeks (plus optional unlimited weeks)
Primary Mood Mood levels reported by visual analogue scale ("how was your mood yesterday?"; 0-10; where 10 is most positive) 3 weeks (plus optional unlimited weeks)
Primary Energy Energy levels reported by visual analogue scale ("how energetic did you feel yesterday?"; 0-10; where 10 is most energetic) 3 weeks (plus optional unlimited weeks)
Primary Symptom burden The self-reported symptom burden while completing both habitual and TRE phases 3 weeks (plus optional unlimited weeks)
Secondary Body weight Self-reported in the study app (optional) 3 weeks (plus optional unlimited weeks)
Secondary Gastrointestinal symptoms Gastrointestinal symptoms self-reported by questionnaire 3 weeks (plus optional unlimited weeks)
Secondary Eating habits Eating habits self-reported by questionnaire, including number of main meals and snacks per day 3 weeks (plus optional unlimited weeks)
See also
  Status Clinical Trial Phase
Completed NCT04647149 - Effects of Early and Delayed Time-restricted Eating in Adults With Overweight and Obesity N/A
Completed NCT04953650 - Intermittent Fasting Towards Elevated Blood Pressure N/A
Active, not recruiting NCT05290233 - Time Restricted Eating Plus Exercise for Weight Management N/A
Completed NCT04404413 - High-Intensity Interval Training and Intermittent Fasting on Body Composition and Physical Performance in Active Women N/A
Completed NCT02770313 - Weekly ONe-Day WatER-only Fasting InterventionaL Trial for Low-Density Lipoprotein Cholesterol Reduction N/A
Active, not recruiting NCT05344066 - Manchester Intermittent Diet in Gestational Diabetes Acceptability Study N/A
Not yet recruiting NCT06330610 - Evaluation of the Efficiency of Intermittent Enteral Nutrition on Multi-organ Failure From Patients With Mechanical Ventilation in Intensive Care Unit N/A
Not yet recruiting NCT06299020 - Risks of Intermittent Fasting in Patients With Primary Adrenal Insufficiency N/A
Recruiting NCT03789409 - Intermittent Fasting Following Acute Ischemic Stroke N/A
Not yet recruiting NCT06302231 - Effects of Time-restricted Eating and Aerobic Exercise Training in Women With Overweight and Obesity N/A
Recruiting NCT05760339 - Intermittent Fasting Versus Carbohydrate Drinks Before Surgery N/A
Recruiting NCT06429124 - Time Restricted Eating in Alzheimer's Disease (TREAD) N/A
Enrolling by invitation NCT06105372 - Ramadan Fasting, Microbiota and FABP4
Completed NCT04732130 - Monitoring During Different Intermittent Fasting Protocols in Non-Obese Adults N/A
Completed NCT05422391 - The Acute Effects of Caloric Restriction on Anthropometrics, Metabolism, and Cardiovascular Health in Overweight Adults N/A
Recruiting NCT05136313 - Healthy vs Unhealthy Obesity: Mehanistic Insights and Effects of Time-Restricted Eating N/A
Not yet recruiting NCT06323889 - Longitudinal Monitoring During Intermittent Fasting Protocols in Obese Adults N/A
Completed NCT01378208 - How Often Should We Eat N/A
Recruiting NCT04873648 - Effect of Fasting and Calorie-Restricted Diets on Dopamine and Serotonin Levels Among Obese Women With BED and FA N/A
Recruiting NCT06174259 - Influence of Intermittent Fasting on Locally Advanced Breast Cancer Patients N/A